GDNF: A Neurotrophic and Neuroprotective Factor

Name: GDNF: A Neurotrophic and Neuroprotective Factor
Brand: Sino Biological

Glial cell line-derived neurotrophic factor (GDNF) plays a vital role in promoting motor neuron survival and axon outgrowth. It is being evaluated in clinical trials as a potential therapeutic for Parkinson’s disease. GFL-like drugs are also being developed to treat disorders such as neuropathic pain and addiction.

GDNF belongs to the GDNF family of ligands (GFLs), which also consists of neurturin (NRTN), artemin (ARTN), and persephin (PSPN). These molecules bind to GFRA1, GFRA2, GFRA3, and GFRA4, respectively. GDNF/GFRA1 complex triggers the phosphorylation of RET tyrosine kinase receptor, ultimately eliciting cell survival, proliferation, and development via the MAPK/ERK or PI3K/Akt pathways. GDNF/GFRA1 also complexes with NCAM to induce axonal expansion. In addition, GDNF can synergize with other growth factors, including transforming growth factor-β (TGF-beta).

Sino Biological has developed an array of recombinant GDNF and GFRA1 proteins and antibodies from various species, such as human, mouse, cynomolgus, rabbit, rat, and canine.

About Sino Biological

Sino Biological, an international reagent supplier and service provider, specializes in recombinant protein production and antibody development. All of the products are independently developed and produced, including recombinant proteins, antibodies and cDNA. Sino Biological is the researchers' one-stop technical services shop for the advanced technology platforms they need to make advancements and offers pre-clinical production technology services for monoclonal antibody drug candidates.

Interested in seeing more content from Sino Biological?

Discover all their latest news, webinars, products and more by clicking the link below.

Chosen for You